Which Statin is Best for the Kidneys?
Curr Vasc Pharmacol
.
2023;21(1):1-3.
doi: 10.2174/1570161121666221202154440.
Authors
Peter E Penson
1
2
,
Maciej Banach
3
4
,
Alice P McCloskey
1
Affiliations
1
Clinical Pharmacy & Therapeutics Research Group, School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
2
Liverpool Centre for Cardiovascular Science, Liverpool, UK.
3
Department of Hypertension, Medical University of Lodz, Lodz, Poland.
4
Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.
PMID:
36476436
DOI:
10.2174/1570161121666221202154440
No abstract available
Publication types
Editorial
MeSH terms
Cardiovascular Diseases*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Kidney
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors